Evidence map›Paper›PMID 39348445›Full record

ArticlePLoS pathogens2024

Novel multiphoton intravital imaging enables real-time study of Helicobacter pylori interaction with neutrophils and macrophages in the mouse stomach.

Hellen Ishikawa-Ankerhold, Benjamin Busch, Almke Bader, Daniela Maier-Begandt, Flavio Dionisio, Sukumar Namineni, Mykhailo Vladymyrov, Ute Harrison, Dominic van den Heuvel, Lukas Tomas and 4 more

Abstract read
In one paragraph

Article in PLoS pathogens, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Hellen Ishikawa-AnkerholdDepartment of Internal Medicine I, LMU University Hospital, Munich, Germany.
Benjamin BuschChair of Medical Microbiology and Hospital Epidemiology, Max von Pettenkofer Institute, Faculty of Medicine, LMU Munich, Germany.
Almke BaderInstitute of Surgical Research at the Walter-Brendel-Centre of Experimental Medicine, LMU University Hospital, Munich, Germany.
Daniela Maier-BegandtInstitute of Surgical Research at the Walter-Brendel-Centre of Experimental Medicine, LMU University Hospital, Munich, Germany.
Flavio DionisioDepartment of Internal Medicine I, LMU University Hospital, Munich, Germany.
Sukumar NamineniChair of Medical Microbiology and Hospital Epidemiology, Max von Pettenkofer Institute, Faculty of Medicine, LMU Munich, Germany.
Mykhailo VladymyrovData Science Lab, Mathematical Institute, University of Bern, Bern, Switzerland.
Ute HarrisonChair of Medical Microbiology and Hospital Epidemiology, Max von Pettenkofer Institute, Faculty of Medicine, LMU Munich, Germany.
Dominic van den HeuvelDepartment of Internal Medicine I, LMU University Hospital, Munich, Germany.
Lukas TomasDepartment of Internal Medicine I, LMU University Hospital, Munich, Germany.
Barbara WalzogInstitute of Surgical Research at the Walter-Brendel-Centre of Experimental Medicine, LMU University Hospital, Munich, Germany.
Steffen MassbergDepartment of Internal Medicine I, LMU University Hospital, Munich, Germany.
Christian SchulzDepartment of Internal Medicine I, LMU University Hospital, Munich, Germany.
Rainer HaasGerman Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Munich, Germany.ORCID 0000-0002-2761-0947

Funding

German Research Foundation (DFG) SFB914
6 · The paper itself

Abstract

Helicobacter pylori (H. pylori) is a bacterial pathogen that exclusively colonizes the human gastric mucosa and can cause persistent infection. In this process, H. pylori employs various strategies to avoid recognition by the human immune system. These range from passive defense strategies (e.g., altered LPS or flagellin structures) that prevent recognition by pattern recognition receptors (PRRs) to more active approaches, such as inhibition of IL-2 secretion and proliferation of T cells via VacA. Despite the growing evidence that H. pylori actively manipulates the human immune system for its own benefit, the direct interaction of H. pylori with immune cells in situ is poorly studied. Here, we present a novel intravital imaging model of the murine stomach gastric mucosa and show for the first time the in situ recruitment of neutrophils during infection and a direct H. pylori-macrophage interaction. For this purpose, we applied multiphoton intravital microscopy adapted with live drift correction software (VivoFollow) on LysM-eGFP and CX3CR1-eGFP reporter mice strains in which specific subsets of leukocytes are fluorescently labeled. Multiphoton microscopy is proving to be an excellent tool for characterizing interactions between immune cells and pathogens in vivo.

Indexed as

Helicobacter InfectionsHelicobacter pyloriIntravital MicroscopyMacrophagesMicroscopy, Fluorescence, MultiphotonNeutrophilsAnimalsGastric MucosaMiceMice, Inbred C57BLStomach

Identifiers

PMID39348445
PMCPMC11478878

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.